HUP0000419A2 - Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid - Google Patents
Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acidInfo
- Publication number
- HUP0000419A2 HUP0000419A2 HU0000419A HUP0000419A HUP0000419A2 HU P0000419 A2 HUP0000419 A2 HU P0000419A2 HU 0000419 A HU0000419 A HU 0000419A HU P0000419 A HUP0000419 A HU P0000419A HU P0000419 A2 HUP0000419 A2 HU P0000419A2
- Authority
- HU
- Hungary
- Prior art keywords
- acid
- pharmaceutical preparation
- stearidonic
- eicosapentaenoic
- schizophrenia
- Prior art date
Links
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 title abstract 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 title abstract 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 title abstract 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 title abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 title abstract 2
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 2
- 201000000980 schizophrenia Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
Abstract
Pharmaceutical preparation for treatment of schizophrenia and/or tardive dyskinesia comprises an oil comprising eicosapentaenoic acid (I) and/or stearidonic acid (II) in amounts of >20 (preferably >70) weight % of the total (preferably of the total unsaturated) fatty acids present. Also claimed is the use of (I) and/or (II) in the preparation of a medicament for the treatment of schizophrenia and/or tardive dyskinesia or depression or Alzheimer's disease or other dementias in the above form for the administration of 10 mg - 100 g (preferably 500 mg - 10 g) (I) and/or (II) daily, preferably with the (I)/(II) to DHA ratio not less than 3:1 especially 4:1 or more and a weight ratio of (I)/(II) to n-6 EFAs (if present) of not less than 3:1 especially 4:1 or more.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9626062.5A GB9626062D0 (en) | 1996-10-11 | 1996-12-16 | Fatty acid treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0000419A2 true HUP0000419A2 (en) | 2000-08-28 |
| HUP0000419A3 HUP0000419A3 (en) | 2000-11-28 |
Family
ID=10804499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000419A HUP0000419A3 (en) | 1996-12-16 | 1997-10-07 | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP0000419A3 (en) |
-
1997
- 1997-10-07 HU HU0000419A patent/HUP0000419A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0000419A3 (en) | 2000-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW429145B (en) | Pharmaceutical composition for treating schizophrenia, tardive dyskinesia, depression, and alzheimer's disease comprising EPA/SA | |
| NZ299464A (en) | Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea | |
| CA2033823C (en) | Combination of gla or dgla and selenium in psychiatric disorder treatment | |
| PT1152755E (en) | ESSENTIAL FATTY ACIDS INTENDED FOR THE PREVENTION OF CARDIOVASCULAR ACCIDENTS | |
| KR940018091A (en) | Prescriptions Containing Unsaturated Fatty Acids | |
| CA1310911C (en) | Essential fatty acid compositions | |
| BR0309740A (en) | Use of eicosapentaenoic acid (epa), docosaexaenoic acid (dha) or a mixture of epa and dha or a pharmaceutically acceptable salt or derivative thereof | |
| FI970298A0 (en) | Use of DHA as a pharmaceutical composition | |
| CA2073913A1 (en) | Preparation of fatty acid medicaments | |
| ID15895A (en) | FORMULATION TO REDUCE BLOOD CHOLESTEROLS AND ABSORPTION OF FUNCTION OF FATS | |
| GR3035613T3 (en) | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids | |
| HUP0000419A2 (en) | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid | |
| KR930012009A (en) | How to prevent reclosure of arteries | |
| Eritsland et al. | Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile | |
| MY129218A (en) | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid | |
| RU99109049A (en) | PHARMACEUTICAL PRODUCT CONTAINING EICOSAPENTIC ACID AND / OR STEARIDIC ACID | |
| TH58453A (en) | Fatty acid therapy | |
| Wenderoth | Aspects of the new eicosanoid-research.). | |
| TH58453B (en) | Fatty acid therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |